Increased risk of severe acute pancreatitis in patients with diabetes

Diabetic Medicine

Volumn 29, Issue 11, 2012, Pages 1419-1424

  Shen, H N ^a,b   Chang, Y H ^b   Chen, H F ^c,d   Lu, C L ^a,b   Li, C Y ^b,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATITIS; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; TAIWAN;

EID: 84867221155     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2012.03680.x     Document Type: Article

References (26)

1. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas 2006; 33: 323-330.
2. Shen HN, Lu CL, Li CY. Epidemiology of first-attack acute pancreatitis in Taiwan from 2000 through 2009: a nationwide population-based study. Pancreas 2012. doi: 10.1097/MPA.0b013e31823db941.
3. Shen HN, Lu CL. Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in Taiwan. Pancreas 2011; 40: 10-15.
4. Gravante G, Garcea G, Ong SL, Metcalfe MS, Berry DP, Lloyd DM et al.Prediction of mortality in acute pancreatitis: a systematic review of the published evidence. Pancreatology 2009; 9: 601-614.
5. Martinez J, Johnson C, Sanchez-Paya J, De Madaria E, Robles-Diaz G, Perez-Mateo M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006; 6: 206-209.
6. Lloret Linares C, Pelletier AL, Czernichow S, Vergnaud AC, Bonnefont-Rousselot D, Levy P et al.Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia. Pancreas 2008; 37: 13-18.
7. Lankisch PG, Weber-Dany B, Maisonneuve P, Lowenfels AB. Frequency and severity of acute pancreatitis in chronic dialysis patients. Nephrol Dial Transplant 2008; 23: 1401-1405.
8. Pascual-Ramos V, Duarte-Rojo A, Villa AR, Hernandez-Cruz B, Alarcon-Segovia D, Alcocer-Varela J et al.Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol 2004; 31: 707-712.
9. Blomgren KB, Sundstrom A, Steineck G, Wiholm BE. Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care 2002; 25: 298-302.
10. Eland IA, Sundstrom A, Velo GP, Andersen M, Sturkenboom MC, Langman MJ et al.Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP). Scand J Gastroenterol 2006; 41: 1484-1490.
11. Noel RA, Braun DK, Patterson RE, Bloomgren GL. Increased risk of acute pancreatitis and biliary disease observed in patients with type2 diabetes: a retrospective cohort study. Diabetes Care 2009; 32: 834-838.
12. Gonzalez-Perez A, Schlienger RG, Rodriguez LA. Acute pancreatitis in association with type2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care 2010; 33: 2580-2585.
13. Girman CJ, Kou TD, Cai B, Alexander CM, O'Neill EA, Williams-Herman DE et al.Patients with type2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obes Metab 2010; 12: 766-771.
14. Garg R, Chen W, Pendergrass M. Acute pancreatitis in type2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes Care 2010; 33: 2349-2354.
15. Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol 2011; 106: 1697-1704.
16. US Food and Drug Administration. Information for Healthcare Professionals: Exenatide (Marketed as Byetta)-8/2008 Update. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124713.htm Last accessed 20 December 2011.
17. US Food and Drug Administration. Information for Healthcare Professionals: Acute Pancreatitis and Sitagliptin (Marketed as Januvia and Janumet). Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm Last accessed 20 December 2011.
18. Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010; 52: 155-163.
19. Chen HF, Chen P, Li CY. Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan. Diabetes Care 2011; 34: 1177-1179.
20. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.
21. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG et al.Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-591.
22. Tan HF, Tseng HF, Chang CK, Lin W, Hsiao SH. Accessibility assessment of the health care improvement program in rural Taiwan. J Rural Health 2005; 21: 372-377.
23. Sanyal J, Chakraborty DP, Sarkar B, Banerjee TK, Mukherjee SC, Ray BC et al.Environmental and familial risk factors of Parkinsons disease: case-control study. Can J Neurol Sci 2010; 37: 637-642.
24. Dore DD, Seeger JD, Arnold Chan K. Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin 2009; 25: 1019-1027.
25. Olansky L. Q: Do incretin drugs for type2 diabetes increase the risk of acute pancreatitis?Cleve Clin J Med 2010; 77: 503-505.
26. Chuang LM, Tsai ST, Huang BY, Tai TY. The current state of diabetes management in Taiwan. Diabetes Res Clin Pract 2001; 54: S55-S65.